MILWAUKEE (AP) — Alexis Díaz is back in the major leagues and ready to make his debut with the Los Angeles Dodgers, who acquired the 2023 All-Star reliever from the Cincinnati Reds over a month ago.
Los Angeles called up Díaz and sent right-hander Julian Fernández to Triple-A Oklahoma City before the NL West-leading Dodgers fell 3-1 to the Milwaukee Brewers for their fifth straight loss.
The 28-year-old Díaz came to the Dodgers in a May 29 trade that sent minor league pitcher Mike Villani to the Reds. He had been with Triple-A Oklahoma City ever since, going 0-1 with a 9.64 earned run average in six appearances.
While at Oklahoma City, Díaz walked seven and struck out three over 4 2/3 innings.
“I think that there’s been some good and some not-so-good, just trying to be consistent with the delivery,” Dodgers manager Dave Roberts said. “The arm still works. The stuff is still good. But the consistency of strike-throwing is what we haven’t seen yet from Alexis.”
This has been a difficult season for Díaz. He opened the season on the injured list with a left hamstring strain, then went 0-0 with a 12.00 ERA in six appearances with Cincinnati. He lost his job as the Reds’ closer and was eventually sent to the minors before getting traded to the Dodgers.
Díaz is the younger brother of New York Mets closer Edwin Díaz. He totaled 75 saves with the Reds from 2022-24.
The 29-year-old Fernández was called up Monday and allowed two runs over two innings in a 9-1 loss to the Brewers. He is 3-0 with a 4.08 ERA in 24 games with Oklahoma City.
In other Dodgers pitching news, right-hander Tyler Glasnow is expected to return from the injured list and start Wednesday’s game at Milwaukee. Glasnow has been dealing with shoulder inflammation and last pitched for the Dodgers on April 27.
“I’m excited to get him back on the mound," Roberts said. "He’s excited to be back on the mound. We’ll see, but I’m expecting him to pitch well.”
AP MLB: https://apnews.com/hub/MLB
FILE - Cincinnati Reds relief pitcher Alexis Díaz works in the eighth inning of a baseball game, April 26, 2025, in Denver. (AP Photo/David Zalubowski, File)
President Donald Trump made a lot of tariff threats and trade promises this year. Many materialized into a barrage of new import taxes that overturned decades of U.S. economic policy — but others have yet to be fulfilled as 2025 comes to a close.
Some of Trump’s unrealized threats reflect a broader approach from a president with a track record of using sky-high levies to pressure other countries into new trade deals, one-up retaliatory measures or even punish political critics. At the same time, they arrived as growing list of tariffs did go into effect — from Trump's punishing new taxes on imported metals, to tit-for-tat levies with top U.S. trading partners like China — plunging consumers and businesses worldwide into uncertainty.
Here’s what Trump said when announcing some of his biggest (but still unrealized) tariff threats and promises this year, and where things stand today.
In his words:
What happened: The External Revenue Service has yet to be established as of the end of December. While administration officials continued to reiterate plans for launching the External Revenue Service during Trump's first months back in office, the entity does not yet exist.
In his words:
What happened: The EU's planned levy on American whiskey — which it unveiled as part of broader retaliation in response to Trump's new steel and aluminum tariffs — was postponed, with the latest delay reportedly running until at least February.
Trump's 200% tariff threat on European alcohol never materialized. But spirits were not included in the EU-U.S. trade deal struck over the summer, which set a 15% rate on most European imports.
In his words:
What happened: Despite Trump's repeated threats, the U.S. has yet to impose a 100% tariff on foreign films. After his initial May promise to initiate the process, the White House said no final decision had been made. Also still unclear is how the U.S. would tax a movie made overseas.
In his words:
What happened: The president did not sign an executive order imposing a 100% tariff on pharma products on Oct. 1 and, as of today, no levy has been put into place. But Trump previously suggested that steep levies on pharmaceutical drugs could arrive further down the road, telling CNBC in August that he would start by charging a “small tariff” and potentially raise the rate as high as 250%. Meanwhile, trade agreements with specific countries set their own rates or exemptions — with the U.K., for example, securing a 0% tariff on all British medicine exported to the U.S. for three years. The administration also announced deals with specific companies with promises of lower drug prices.
In his words:
What happened: A sweeping 100% on computer chips has yet to go into effect. When announcing his plans to impose the levy back in August, Trump was not specific about the timing. And other details have remained scarce.
In his words:
What happened: Details about how, when and if a tariff dividend will reach Americans are still scarce. Budget experts have said that the math doesn't add up. And Treasury Secretary Scott Bessent suggested that it might not mean checks from the government. Instead, Bessent told ABC in November, the rebate might take the form of tax cuts. White House National Economic Council Director Kevin Hassett also told CBS News that it's up to Congress.
FILE - President Donald Trump speaks during an event to announce new tariffs in the Rose Garden at the White House, on April 2, 2025, in Washington. (AP Photo/Mark Schiefelbein, File)
